Title : Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers.

Pub. Date : 2011 Dec

PMID : 21431842






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Surgical specimens from COX-2 positive endometrial cancer patients treated with etodolac had significantly reduced expression levels of COX-2, Ki-67, p53, p21, p27, and cyclin D1 as determined by immunohistochemistry, while AI was not affected. Etodolac tumor protein p53 Homo sapiens